Endothelin-converting enzyme 1

Handbook of Proteolytic Enzymes, Second Edition: Volume 1: Aspartic and Metallo Peptidases

Volumn 1, Issue , 2004, Pages 429-434

  Ahn, Kyunghye ^a   Johnson, Gary D ^b  

^a PFIZER INC   (United States)

^b R and D Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14844307227     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-079611-3.50118-X     Document Type: Chapter

References (63)

1. K. Ahn, K. Beningo, G. Olds and D. Hupe (1992) The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 89 8606-8610.
2. K. Ahn, S. Pan, K. Beningo and D. Hupe (1995) A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells. Life Sci. 56 2331-2341.
3. K. Ahn, A.M. Sisneros, S.B. Herman, S.M. Pan, D. Hupe, D. Lee, S. Nikam, X.-M. Cheng, A.M. Doherty, R.L. Schroeder, S.J. Haleen, S. Kaw, N. Emoto and M. Yanagisawa (1998) Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem. Biophys. Res. Commun. 243 184-190.
4. K. Ahn, S.B. Herman and D.C. Fahnoe (1998) Soluble human endothelin-converting enzyme-1: Expression, purification, and demonstration of pronounced pH sensitivity. Arch. Biochem. Biophys. 359 258-268.
5. A. Azarani, G. Boileau and P. Crine (1998) Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells. Biochem. J. 333 439-448.
6. K. Barnes, C. Brown and A.J. Turner (1998) Endothelin-converting enzyme: Ultrastructural localization and its recycling from the cell surface. Hypertension 31 3-9.
7. A.G. Baynash, K. Hosoda, A. Giaid, J.A. Richardson, N. Emoto, R.E. Hammer and M. Yanagisawa (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79 1277-1285.
8. D. Bur, G.E. Dale and C. Oefner (2001) A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP). Protein Eng. 14 337-341.
9. S. Chackalamannil, S. Chung, A.W. Stamford, B.A. McKittrick, Y. Wang, H. Tsai, R. Cleven, A. Fawzi and M. Czarniecki (1996) Highly potent and selective inhibitors of endothelin converting enzyme. Bioorg. Med. Chem. Lett. 6 1257-1260.
10. D.E. Clouthier, K. Hosoda, J.A. Richardson, S.C. Williams, H. Yanagisawa, T. Kuwaki, M. Kumada, R.E. Hammer and M. Yanagisawa (1998) Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125 813-824.
11. M. Clozel, V. Breu, K. Burri, J.-M. Cassal, W. Fischli, G.A. Gray, G. Hirth, B.-M. Löffler, M. Müller, W. Neidhart and H. Ramuz (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365 759-761.
12. R. Corder, N. Khan and V.J. Harrison (1995) A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Biochem. Biophys. Res. Commun. 207 355-362.
13. A.P. Davenport, R.E. Kuc, C. Plumpton, J.W. Mockridge, P.J. Barker and N.S. Huskisson (1998) Endothelin-converting enzyme in human tissues. Histochem. J. 30 359-374.
14. S. De Lombaert, R.D. Ghai, A.Y. Jeng, A.J. Trapani and R.L. Webb (1994) Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem. Biophys. Res. Commun. 204 407-412.
15. S. De Lombaert, L.B. Stamford, L. Blanchard, J. Tan, D. Hoyer, C.G. Diefenbacher, D. Wei, E.M. Wallace, M.A. Moskal, P. Savage and A.Y. Jeng (1997) Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett. 7 1059-1064.
16. S. De Lombaert, L. Blanchard, L.B. Stamford, J. Tan, E.M. Wallace, Y. Satoh, J. Fitt, D. Hoyer, D. Simonsbergen, J. Moliterni, N. Marcopoulos, P. Savage, M. Chou, A.J. Trapani and A.Y. Jeng (2000) Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action. J. Med. Chem. 43 488-504.
17. P. Deprez, J. Guillaume, J. Dumas and J.-P. Vevert (1996) Thiol inhibitors of endothelin-converting enzyme. Bioorg. Med. Chem. Lett. 6 2317-2322.
18. N. Emoto, Y. Nurhantari, H. Alimsardjono, J. Xie, T. Yamada, M. Yanagisawa and M. Matsuo (1999) Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-Ia mediated by novel signals in its alternatively spliced cytoplasmic tail. J. Biol. Chem. 274 1509-1518.
19. D.C. Fahnoe, G.D. Johnson, S.B. Herman and K. Ahn (2000) Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp21-Val22 bond by soluble endothelin-converting enzyme-1 from baculovirus/insect cells. Arch. Biochem. Biophys. 373 385-393.
20. D.C. Fahnoe, J. Knapp, G.D. Johnson and K. Ahn (2000) Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH. J. Cardiovasc. Pharmacol. 36(suppl 1), S22-S25.
21. T. Fukuroda, K. Noguchi, S. Tsuchida, M. Nishikibe, F. Ikemoto, K. Okada and M. Yano (1990) Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 172 390-395.
22. G. Gui, D. Xu, N. Emoto and M. Yanagisawa (1993) Intracellular localization of membrane-bound endothelin-converting enzyme from rat lung. J. Cardiovasc. Pharmacol. 22(suppl 8), S53-S56.
23. M.V. Hoang and A.J. Turner (1997) Novel activity of endothelin-converting enzyme – hydrolysis of bradykinin. Biochem. J. 327 23-26.
24. H.Y.P Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet. 11, 130–136
25. K. Ikeda, N. Emoto, S.B. Raharjo, Y. Nurhantari, K. Saiki, M. Yokoyama and M. Matsuo (1999) Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J. Biol. Chem. 274 32469-32477.
26. R. Ikegawa, Y. Matsumura, Y. Tsukahara, M. Takaoka and S. Morimoto (1990) Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem. Biophys. Res. Commun. 171 669-675.
27. A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto and T. Masaki (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86 2863-2867.
28. A.Y. Jeng and S. De Lombaert (1997) Endothelin converting enzyme inhibitors. Curr. Pharm. Design 3 579-614.
29. G.D. Johnson and K. Ahn (2000) Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1. Anal. Biochem. 286 112-118.
30. G.D. Johnson, T. Stevenson and K. Ahn (1999) Hydrolysis of peptide hormones by endothelin-converting enzyme-1: A comparison with neprilysin. J. Biol. Chem. 274 4053-4058.
31. G.D. Johnson, H.R. Swenson, R. Ramage and K. Ahn (2002) Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: A comparison with neprilysin. Arch. Biochem. Biophys. 398 240-248.
32. W. Kiowski, G. Sütsch, P. Hunziker, P. Müller, J. Kim, E. Oechslin, R. Schmitt, R. Jones and O. Bertel (1995) Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346 732-736.
33. S. Kiryu-Seo, M. Sasaki, H. Yokohama, S. Nakagomi, T. Hirayama, S. Aoki, K. Wada and H. Kiyama (2000) Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers. Proc. Natl. Acad. Sci. USA 97 4345-4350.
34. P. Korth, R.M. Bohle, P. Corvol and F. Pinet (1999) Cellular distribution of endothelin-converting enzyme in human tissues. J. Histochem. Cytochem. 47 447-461.
35. P.J. Kukkola, N.A. Bilci, W.X. Kozak, P. Savage and A.J. Jeng (1996) Optimization of retro-thiorphan for inhibition of endothelin converting enzyme. Bioorg. Med. Chem. Lett. 6 619-624.
36. Y. Kurihara, H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, R. Nagai, H. Oda, T. Kuwaki, W.-H. Cao, N. Kamada, K. Jishage, Y. Ouchi, S. Azuma, Y. Toyoda, T. Ishikawa, M. Kumada and Y. Yazaki (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368 703-710.
37. B.-M. Löffler (1999) ACE, NEP, ECE-1: Selective and combined inhibition. Curr. Opin. Cardiovasc., Pulm. Renal Invest. Drugs 1 352-364.
38. K.J. MacLeod, R.S. Fuller, J.D. Scholten and K. Ahn (2001) Conserved cysteine and tryptophan residues of the endothelin-converting enzyme-1 CXAW motif are critical for protein maturation and enzyme activity. J. Biol. Chem. 276 30608-30614.
39. Y. Matsumura, K. Hisaki, M. Takaoka and S. Morimoto (1990) Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur. J. Pharmacol. 185 103-106.
40. B.A. McKittrick, A.W. Stamford, X. Weng, K. Ma, S. Chackalamannil, M. Czarniecki, R.M. Cleven and A.B. Fawzi (1996) Design and synthesis of phosphinic acids that triply inhibit endothelin converting enzyme, angiotensin converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett. 6 1629-1634.
41. L.J. Murphy, R. Corder, A.I. Mallet and A.J. Turner (1994) Generation by the phosphoramidon-sensitive peptidases, endopeptidase-24.11 and thermolysin, of endothelin-1 and C-terminal fragment from big endothelin-1. Br. J. Pharmacol. 113 137-142.
42. C. Oefner, A. D'Arch, M. Hennig, F.K. Winkler and G.E. Dale (2000) Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J. Mol. Biol. 296 341-349.
43. K. Ohnaka, R. Takayanagi, M. Nishikawa, M. Haji and H. Nawata (1993) Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. J. Biol. Chem. 268 26759-26766.
44. T.R. Patel, S.L. Galbraith, M.A. McAuley, A.M. Doherty, D.I. Graham and J. McCulloch (1995) Therapeutic potential of endothelin receptor antagonists in experimental stroke. J. Cardiovasc. Pharmacol. 26(suppl 3), S412-S415.
45. E.G. Puffenberger, K. Hosoda, S.S. Washington, K. Nakao, D. deWit, M. Yanagisawa and A. Chakravarti (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79 1257-1266.
46. B.P. Roques, F. Noble, V. Daugé, M.-C. Fournié-Zaluski and A. Beaumont (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45 87-146.
47. G.P. Rossi, G. Albertin, E. Franchin, A. Sacchetto, M. Cesari, G. Palú and A.C. Pessina (1995) Expression of the endothelin-converting enzyme gene in human tissues. Biochem. Biophys. Res. Commun. 211 249-253.
48. T. Sawamura, Y. Kasuya, Y. Matsushita, N. Suzuki, O. Shinmi, N. Kishi, Y. Sugita, M. Yanagisawa, K. Goto, T. Masaki and S. Kimura (1991) Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem. Biophys. Res. Commun. 174 779-784.
49. M. Schmidt, B. Kröger, E. Jacob, H. Seulberger, T. Subkowski, R. Otter, T. Meyer, G. Schmalzing and H. Hillen (1994) Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356 238-243.
50. A. Schweizer, O. Valdenaire, P. Nelböck, U. Deuschle, J.-B.D.M. Edwards, J.G. Stumpf and B.-M. Löffler (1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem. J. 328 871-877.
51. N.G. Seidah, R. Day, M. Marcinkiewicz and M. Chrétien (1993) Mammalian paired basic amino acid convertases of prohormones and proproteins. Ann. NY Acad. Sci. 680 135-146.
52. K. Shimada, M. Takahashi and K. Tanzawa (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 269 18275-18278.
53. K. Shimada, Y. Matsushita, K. Wakabayashi, M. Takahashi, A. Matsubara, Y. Iijima and K. Tanzawa (1995) Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun. 207 807-812.
54. K. Shimada, M. Takahashi, A.J. Turner and K. Tanzawa (1996) Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem. J. 315 863-867.
55. M. Takahashi, Y. Matsushita, Y. Iijima and K. Tanzawa (1993) Purification and characterization of endothelin-converting enzyme from rat lung. J. Biol. Chem. 268 21394-21398.
56. M. Takahashi, K. Fukuda, K. Shimada, K. Barnes, A.J. Turner, M. Ikeda, H. Koike, Y. Yamamoto and K. Tanzawa (1995) Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem. J. 311 657-665.
57. A.J. Turner and L.J. Murphy (1996) Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51 91-102.
58. O. Valdenaire, E. Rohrbacher and M.-G. Mattei (1995) Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270 29794-29798.
59. O. Valdenaire, D. Lepailleur-Enouf, G. Egidy, A. Thouard, A. Barret, R. Vranckx, C. Tougard and J.B. Michel (1999) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter: molecular cloning and characterization. Eur. J. Biochem. 264 341-349.
60. O. Valdenaire, A. Barret, A. Schweizer, E. Rohrbacher, F. Mongiat, F. Pinet, P. Corvol and C. Tougard (1999) Two dileucine-based motifs account for the different subcellulare localizations of the human endothelin-converting enzyme (ECE-1) isoforms. J. Cell Sci. 112 3115-3125.
61. D. Xu, N. Emoto, A. Giaid, C. Slaughter, S. Kaw, D. deWit and M. Yanagisawa (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78 473-485.
62. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto and T. Masaki (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 411-415.
63. H. Yanagisawa, M. Yanagisawa, R.P. Kapur, J.A. Richardson, S.C. Williams, D.E. Clouthier, D. de Wit, N. Emoto and R.E. Hammer (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125 825-836.